Point72 Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-292,647
| Closed | -$11.6M | – | 2498 |
|
|
2025
Q2 | $11.6M | Buy |
292,647
+5,443
| +2% | +$178K | 0.02% | 677 |
|
|
2025
Q1 | $8.66M | Buy |
+287,204
| New | +$9.41M | 0.02% | 735 |
|
|
2024
Q3 | – | Sell |
-137,210
| Closed | -$6.54M | – | 2166 |
|
|
2024
Q2 | $6.54M | Sell |
137,210
-149,392
| -52% | -$6.13M | 0.02% | 767 |
|
|
2024
Q1 | $12.4M | Sell |
286,602
-682,198
| -70% | -$32.5M | 0.03% | 636 |
|
|
2023
Q4 | $49M | Buy |
968,800
+827,300
| +585% | +$39.6M | 0.12% | 221 |
|
|
2023
Q3 | $6.42M | Sell |
141,500
-62,900
| -31% | -$2.6M | 0.02% | 806 |
|
|
2023
Q2 | $8.39M | Buy |
204,400
+108,515
| +113% | +$4.17M | 0.02% | 643 |
|
|
2023
Q1 | $3.43M | Buy |
+95,885
| New | +$3.6M | 0.01% | 875 |
|
|
2022
Q3 | – | Sell |
-13,185
| Closed | -$488K | – | 1544 |
|
|
2022
Q2 | $488K | Buy |
+13,185
| New | +$497K | ﹤0.01% | 1190 |
|
|
2022
Q1 | – | Sell |
-53,981
| Closed | -$1.64M | – | 1276 |
|
|
2021
Q4 | $1.64M | Sell |
53,981
-165,319
| -75% | -$5.2M | 0.01% | 849 |
|
|
2021
Q3 | $7.36M | Sell |
219,300
-757,600
| -78% | -$28.5M | 0.03% | 563 |
|
|
2021
Q2 | $39M | Buy |
+976,900
| New | +$38.3M | 0.18% | 155 |
|
|
2021
Q1 | – | Sell |
-402,400
| Closed | -$22.8M | – | 1062 |
|
|
2020
Q4 | $22.8M | Buy |
402,400
+113,908
| +39% | +$5.68M | 0.11% | 253 |
|
|
2020
Q3 | $13.7M | Buy |
288,492
+113,867
| +65% | +$6.33M | 0.07% | 339 |
|
|
2020
Q2 | $10.3M | Buy |
174,625
+169,052
| +3,033% | +$9.4M | 0.07% | 329 |
|
|
2020
Q1 | $263K | Buy |
+5,573
| New | +$311K | ﹤0.01% | 705 |
|
|
2018
Q4 | – | Sell |
-86,031
| Closed | -$4.44M | – | 1082 |
|
|
2018
Q3 | $4.44M | Buy |
+86,031
| New | +$4.04M | 0.02% | 626 |
|
|
2017
Q4 | – | Sell |
-25,000
| Closed | -$1.27M | – | 982 |
|
|
2017
Q3 | $1.27M | Buy |
+25,000
| New | +$1.31M | 0.01% | 718 |
|
|
2016
Q2 | – | Sell |
-80,600
| Closed | -$3.26M | – | 796 |
|
|
2016
Q1 | $3.26M | Sell |
80,600
-217,300
| -73% | -$8.83M | 0.03% | 500 |
|
|
2015
Q4 | $18.4M | Buy |
297,900
+226,400
| +317% | +$12.2M | 0.15% | 173 |
|
|
2015
Q3 | $2.89M | Sell |
71,500
-68,600
| -49% | -$3.55M | 0.02% | 515 |
|
|
2015
Q2 | $8.06M | Buy |
+140,100
| New | +$8.91M | 0.06% | 365 |
|
Other funds holding IONS
VPM
VCM
Point72 Asset Management's IONS Position: Q3 2025 in Review
Point72 Asset Management sold out of Ionis Pharmaceuticals (IONS) in Q3 2025, closing a stake of 292,647 shares — an estimated $11.6M sold.
Point72 Asset Management first reported a position in IONS in Q2 2015 and held it in 22 quarters. The position peaked at $49M in Q4 2023. 435 funds tracked by Wall St. Rank hold IONS as of Q3 2025.
- Point72 Asset Management reported no remaining Ionis Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
- Point72 Asset Management sold 292,647 Ionis Pharmaceuticals shares in Q3 2025, an estimated $11.6M.
- Point72 Asset Management first reported a position in Ionis Pharmaceuticals in Q2 2015 and held it in 22 quarters.
- Point72 Asset Management's Ionis Pharmaceuticals position peaked at $49M in Q4 2023.
- 435 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2025.
Based on Point72 Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.